Target achievement and cardiovascular event rates with Lomitapide in homozygous Familial Hypercholesterolaemia

Homozygous familial hypercholesterolaemia (HoFH) is characterized by a markedly increased risk of premature cardiovascular (CV) events and cardiac death. Lomitapide reduces low-density lipoprotein cholesterol ...

Source: Orphanet Journal of Rare Diseases - June 20, 2018 Category: Internal Medicine Authors: Dirk J. Blom, Marina Cuchel, Miranda Ager and Helen Phillips Tags: Research Source Type: research